In an article for Forbes, research affiliate John Werner spotlights Prof. Dina Katabi and her work showcasing how AI can boost the capabilities of clinical data. “We are going to collect data, clinical data from patients continuously in their homes, track the symptoms, the evolution of those symptoms, and process this data with machine learning so that we can get insights before problems occur,” says Katabi.
Michael Goldberg PhD '08 founded Surge Therapeutics, a company developing a hydrogel immunotherapy treatment aimed at reducing the risk of surgically-removed cancers returning, reports India Rice for Forbes. “Broadly speaking, immunotherapy is a range of cancer treatments that aim to strengthen the immune system’s ability to fight cancer,” explains Rice. “But what makes Surge’s solution different is that it’s applied during surgery as opposed to other immunotherapies that are delivered weeks before or weeks after surgery.”
Writing for The New York Times, MIT Prof. Amy Finkelstein and Stanford Prof. Liran Einav note that health insurance coverage for the Americans "who are fortunate enough to have insurance is deeply flawed.” Finkelstein and Einav make the case that the solution to health insurance reform is “universal coverage that is automatic, free and basic.”
Prof. Regina Barzilay speaks with Nicole Estephan of WCVB-TV’s Chronicle about her work developing new AI systems that could be used to help diagnose breast and lung cancer before the cancers are detectable to the human eye.
Wall Street Journal reporter Emily Bobrow spotlights Laurel Braitman PhD '13 for her work teaching writing and communication skills to healthcare workers. “We need people who are trained in science and medicine to be able to tell stories about what matters in public health in a way that makes people listen,” says Braitman. “But to do that, they have to be in touch with what they really feel.”
Prof. Marzyeh Ghassemi speaks with NPR host Kate Wells about a decision by the National Eating Disorders Associations to replace their helpline with a chatbot. “I think it's very alienating to have an interactive system present you with irrelevant or what can feel like tangential information,” says Ghassemi.
Prof. Bruce Walker and his team have found that CD8+ T cells can allow HIV patients to control the virus without the use of medications, reports Alan Mozes for HealthDay. “About one in 300 people are able to control HIV without the need for medications,” says Walker. “[It appears] that it is the CD8+ T cell response that achieves this control.”
Soledad O’Brien spotlights how researchers from MIT and Massachusetts General Hospital developed a new artificial intelligence tool, called Sybil, that an accurately predict a patient’s risk of developing lung cancer. “Sybil predicted with 86 to 94 percent accuracy whether a patient would develop lung cancer within a year,” says O’Brien.
Prof. Marzyeh Ghassemi speaks with NPR host Emily Kwong and correspondent Geoff Brumfiel about how artificial intelligence could impact medicine. “When you take state-of-the-art machine-learning methods and systems and then evaluate them on different patient groups, they do not perform equally,” says Ghassemi.
Research from MIT and elsewhere have developed a mobile app that uses computer-vision techniques and AI to detect post-surgery signs of infection as part of an effort to help community workers in Kirehe, a district in Rwanda’s Eastern province, reports Shefali Malhotra for Science. “The researchers are now improving the app so it can be used across more diverse populations such as in Ghana and parts of South America,” writes Malhotra.
Researchers at MIT have developed a new nanoparticle sensor that can detect cancerous proteins through a simple urine test. “The researchers designed the tests to be done on a strip of paper, similar to the at-home COVID tests everyone became familiar with during the pandemic,” writes Lambert. “They hope to make it as affordable and accessible to as many patients as possible.”
Writing for MarketWatch, Joseph Coughlin, director of the MIT AgeLab, discusses the importance of ensuring that retirees have access to quality healthcare. “Given demographic shifts in the medical profession as well as healthcare-industry restructuring, understanding where, and from whom, you will be accessing quality personal care that fits your unique health conditions, just when you most need it most, must now be part of an overall longevity plan that extends well beyond money,” writes Coughlin.
NBC News highlights how researchers from MIT and MGH have developed a new AI tool, called Sybil, that can “accurately predict whether a person will develop lung cancer in the next year 86% to 94% of the time.” NBC News notes that according to experts, the tool "could be a leap forward in the early detection of lung cancer.”
Prof. Marzyeh Ghassemi speaks with WBUR reporter Geoff Brumfiel about her research studying the use of artificial intelligence in healthcare. “When you take state-of-the-art machine learning methods and systems and then evaluate them on different patient groups, they do not perform equally,” says Ghassemi.
Prof. Marzyeh Ghassemi speaks with Scientific American reporter Sara Reardon about the impact of AI chatbots on medical care. “Ghassemi is particularly concerned that chatbots will perpetuate the racism, sexism and other types of prejudice that persist in medicine—and across the Internet,” writes Reardon. “Scrubbing racism from the Internet is impossible, but Ghassemi says developers may be able to do preemptive audits to see where a chatbot gives biased answers and tell it to stop or to identify common biases that pop up in its conversations with users.”